Enzo Biochem, Inc.
ENZ
$0.464
-$0.015-3.13%
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -3.38M | -13.38M | -3.02M | -3.06M | -6.62M |
| Total Depreciation and Amortization | 319.00K | 398.00K | 337.00K | 267.00K | 270.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 445.00K | 3.46M | 1.25M | -387.00K | 2.48M |
| Change in Net Operating Assets | -6.38M | 8.44M | -1.43M | -5.76M | -9.51M |
| Cash from Operations | -8.99M | -1.09M | -2.86M | -8.94M | -13.37M |
| Capital Expenditure | -448.00K | -123.00K | -143.00K | -25.00K | -254.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 5.00M | -- | -- | -- | -- |
| Cash from Investing | 4.55M | -123.00K | -143.00K | -25.00K | -254.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -37.00K | -3.61M | -37.00K | -22.00K | -51.00K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -163.00K | 0.00 | -7.00K | 0.00 | -467.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -200.00K | -3.61M | -44.00K | -22.00K | -518.00K |
| Foreign Exchange rate Adjustments | 2.00K | 32.00K | -36.00K | 19.00K | -20.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.64M | -4.79M | -3.09M | -8.97M | -14.17M |
